Milford MA. – Prestige Scientific is excited to announce the successfully completed search for a Vice President and Head of Clinical Development for our rapidly growing biotechnology partner pioneering a new and differentiated class of therapeutics.
This Vice President will be tasked with providing medical and scientific leadership to a portfolio of programs aimed at developing Nobel Prize-winning revolutionary technology that is expected to change the way we treat certain cancers. Our placement will also lead early development planning and study conduct while thinking strategically during key interactions at the highest leadership levels.
Our client’s mission is to continue the development of their novel class of medicines for diseases that are underserved by existing therapeutics.
Prestige Scientific is the trusted advisor to this clinical-stage biopharmaceutical company developing a novel class of medicines derived from science first conceived in the laboratory of the 2018 Nobel Prize winner in Chemistry. Prestige has since successfully secured a Chief Medical Officer, VP Clinical Development, Director Clinical Sciences, as well as clinical operations and program management hires. Congratulations to Michael Barros for leading this search! Get in touch with Michael, mbarros@prestigescientific.com, or find him on LinkedIn.
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
